Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Craig Bijou Analyst Performance

Analyst at Bank of America

Craig Bijou is a stock analyst at Bank of America in the medical sector, covering 15 publicly traded companies. Over the past year, Craig Bijou has issued 6 stock ratings, including buy, hold, and sell recommendations. While full access to Craig Bijou's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Craig Bijou's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
41 Last 8 Years
Buy Recommendations
78.05% 32 Buy Ratings
Companies Covered
15 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy78.0%32 ratings
Hold12.2%5 ratings
Sell9.8%4 ratings

Out of 41 total stock ratings issued by Craig Bijou at Bank of America, the majority (78.0%) have been Buy recommendations, followed by 12.2% Hold and 9.8% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
66.7% of companies on NASDAQ
10 companies
NYSE
33.3% of companies on NYSE
5 companies

Craig Bijou, an analyst at Bank of America, currently covers 15 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
15 companies
100.0%

Craig Bijou of Bank of America specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
9 companies
60.0%
MED PRODUCTS
5 companies
33.3%
MEDICAL SERVICES
1 company
6.7%

Craig Bijou's Ratings History at Bank of America

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Haemonetics Corporation stock logo
HAE
Haemonetics
5/22/2026Upgrade$61.79$80.00Buy
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2/26/2026Downgrade$27.84$20.00Underperform
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
1/5/2026Boost Price Target$82.82$92.00Neutral
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
12/8/2025Reiterated Rating$35.86$38.00Neutral
Globus Medical, Inc. stock logo
GMED
Globus Medical
11/7/2025Upgrade$61.85$91.00Buy
RxSight, Inc. stock logo
RXST
RxSight
7/9/2025Lower Price Target$7.94$9.00Underperform
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
4/25/2025Lower Price Target$52.56$84.00Buy
RxSight, Inc. stock logo
RXST
RxSight
3/21/2025Lower Price Target$24.90$36.00Buy
Teleflex Incorporated stock logo
TFX
Teleflex
3/4/2025Downgrade$135.31$140.00Underperform
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
2/20/2025Lower Price Target$16.29$17.00Underperform